Immunotherapy Drug Becomes First Therapy Approved by FDA for Rare Skin Cancer – Newswise (press release)
|
Immunotherapy Drug Becomes First Therapy Approved by FDA for Rare Skin Cancer
Newswise (press release) PHOTO CAPTION: Dr. Paul Nghiem, affiliate investigator of the Clinical Research Division at Fred Hutch, and the George F. Odland Endowed Chair in Dermatology at the University of Washington School of Medicine, is a senior investigator on the clinical … |
